Key result
Digoxin therapy in patients with heart failure requires necessary clinical cautions despite its long history of use.
Why the study?
Does digoxin improve survival or reduce hospital admissions in patients with heart failure?
Does digoxin improve survival or reduce hospital admissions in patients with heart failure?
Answers are grounded in this paper and cite their sources.
Evidence from post-hoc subgroup analyses of the DIG trial is insufficient to warrant changing guidelines to prioritize digoxin over proven therapies in heart failure.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Heckman et al. (2007) studied this question. Digoxin therapy in patients with heart failure requires necessary clinical cautions despite its long history of use.
Synapse has enriched 10 related papers. Consider them for comparative context: